95624 ⎘
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or - in which the condensed system contains three hetero rings Peri-condensed systems
SOMATOSTATIN RECEPTOR 2 AGONISTS AND USES THEREOF
#2COMPOUNDS AND THEIR APPLICATIONS
#3RARE EARTH COMPLEX
#4ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#5A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF
#6MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#7MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#8ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT
#9PRC1 INHIBITORS AND METHODS OF TREATMENT THEREWITH
#10Oxazine compound and application thereof
#11Serine/threonine kinase inhibitors
#12Compounds for electronic devices
#13Serine/threonine kinase inhibitors
#14PRC1 inhibitors and methods of treatment therewith
#15CHIMERIC COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF
#16Serine/threonine kinase inhibitors
#17Monosubstituted or polysubstituted amphiphilic hypocrellin derivative, and preparation method and application thereof
#18Chimeric compounds targeting proteins, compositions, methods, and uses thereof
#19Organic electroluminescent materials and devices
#20Serine/threonine kinase inhibitors
#21Chimeric compounds targeting proteins, compositions, methods, and uses thereof
#22Chimeric compounds targeting proteins, compositions, methods, and uses thereof
#23Pentacyclic pyridoindolobenzo[b,e]diazepines and thiazepines for treating CNS disorders
#24Organic electroluminescent materials and devices
#25Organic electroluminescent materials and devices
#26Benzothiazole macrocycles as inhibitors of human immunodeficiency virus replication
#27Macrocyclic compounds as protein kinase inhibitors
#28Organic electroluminescent materials and devices
#29Macrocyclic salt-inducible kinase inhibitors
#30Materials for organic electroluminescent devices
#31MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
#32Serine/threonine kinase inhibitors
#33Materials for organic electroluminescent devices
#34Combination compositions and methods of treatment
#35COMPOUNDS AND METHODS OF TREATING HYPERTENSION
#36Macrocyclic compounds as protein kinase inhibitors
#37Methods of treating diabetes
#38Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#39Organic electroluminescent devices
#40Bridged triarylamines and -phosphines as materials for electronic devices
#41Materials for organic electroluminescent devices
#42Organic electroluminescence device
#43Bimacrocylic HCV NS3 protease inhibitors
#44MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
#45Methods of preparation of macrocyclic compounds
#46Pyridoindolobenzox—and thiazepine derivatives and uses thereof
#47Organic electroluminescence device
#484-SUBSTITUTED-1H-ISOTHIAZOLO[5,4-B][1,4]OXAZINO[2,3,4-IJ]QUINOLINE-7,8(2H,9H)-DIONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS
#49Substituted heterocycle fused γ-carbolines
#508H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
#51Tetracyclic azepinoindole compounds